Health basket committee recommends additions

August 20, 2006 17:13


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

The cabinet was due to consider adding three additional medical technologies, at a cost of approximately NIS 31 million, to the basket of health services. The Health Ministry's basket committee's recommendations included Taxotere for treatment of advanced breast cancer. The addition would aid 350 patients and was expected to cost some NIS 16 million. The committee also recommended pre-implantation genetic diagnosis for 50 women who have had repeated miscarriages due to chromosomal abnormalities, at a cost of NIS 1.72 million, and Myozyme, a treatment for the genetic disorder Pompey's Disease. The recommendations were made on August 10, but they were announced only on Sunday. Funds for expanding the basket was already allocated a few months ago.

Related Content

[illustrative photo]
September 24, 2011
Diabetes may significantly increase risk of dementia